TEXAS CAP BANCSH(US:TCBIO)2025-10-22 20:05Financial Performance - Record-level net income of $105.2 million and diluted earnings per share of $2.18 for Q3 2025, compared to $73.0 million and $1.58 in Q2 2025[2][6] - Net income available to common stockholders for Q3 2025 was $100,897,000, a substantial increase from $73,016,000 in Q2 2025, representing a growth of 37.9%[23] - Adjusted net income for Q3 2025 was $105,210,000, compared to $79,841,000 in Q2 2025, reflecting a 31.8% increase[36] - Basic earnings per common share for Q3 2025 was $2.21, up from $1.59 in Q2 2025, representing a growth of 39.1%[27] - Diluted earnings per share for Q3 2025 were $2.18, an increase from $1.58 in Q2 2025[36] Asset and Loan Growth - Total assets increased to $32,536,980,000 in Q3 2025 from $31,943,535,000 in Q2 2025, reflecting a growth of 1.8%[23] - Total assets as of Q3 2025 were $32,162,709 thousand, up from $31,419,469 thousand in Q2 2025[32] - Total loans held for investment reached $24.2 billion, up from $23.9 billion in Q2 2025[4][8] - Loans held for investment increased to $23,448,533 thousand in Q3 2025, with a yield of 6.42%, compared to $23,068,150 thousand and 6.34% in Q2 2025[32] Income and Revenue - Net interest income increased to $271.8 million in Q3 2025, compared to $253.4 million in Q2 2025, with a net interest margin of 3.47%[8] - Non-interest income increased by $14.5 million in Q3 2025 compared to Q2 2025, driven by higher investment banking and advisory fees[9] - Non-interest income for Q3 2025 was $68.58 million, a significant increase from $54.07 million in Q2 2025[27] - Net interest income for Q3 2025 was $271,771,000, an increase of 7.2% from Q2 2025's $253,395,000[36] Credit Quality and Losses - Provision for credit losses was $12.0 million in Q3 2025, down from $15.0 million in Q2 2025[7] - The provision for credit losses decreased to $12,000,000 in Q3 2025 from $15,000,000 in Q2 2025, indicating improved credit quality[36] - Criticized loans decreased to $529.7 million at the end of Q3 2025, down from $637.5 million at the end of Q2 2025[16] - Total non-performing assets amounted to $96,084 thousand in Q3 2025, down from $113,609 thousand in Q2 2025, representing a decrease of 15.4%[30] Capital and Equity - Stockholders' equity reached $3.6 billion, up from $3.5 billion in Q2 2025[4] - Common Equity Tier 1 ratio increased to 12.1% in Q3 2025 from 11.4% in Q2 2025, indicating stronger capital position[23] - The average common equity for Q3 2025 was $3,324,184,000, compared to $3,195,041,000 in Q2 2025, reflecting a growth in equity base[36] Efficiency and Management - Return on average assets increased to 1.30% in Q3 2025 from 0.99% in Q2 2025[4][6] - The efficiency ratio improved to 56.0% in Q3 2025, down from 61.9% in Q2 2025, demonstrating better cost management[36] - The net interest margin improved to 3.47% in Q3 2025, up from 3.35% in Q2 2025, indicating enhanced profitability[23] Shareholder Actions - The company repurchased 87,087 shares for a total of $7.1 million at an average price of $80.49 per share during Q3 2025[18]